4-(3-(biotinylaminohexamethylenaminocarbonyl)propanoylaminomethyl)-2-methyl-1,3-dithiolane-2-yl-(ala(7))phalloidin has been researched along with Neoplasm Metastasis in 1 studies
*Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diglio, CA; Duniec, ZM; Grossi, IM; Honn, KV; Johnson, CR; Renaud, C; Tang, DG | 1 |
1 other study(ies) available for 4-(3-(biotinylaminohexamethylenaminocarbonyl)propanoylaminomethyl)-2-methyl-1,3-dithiolane-2-yl-(ala(7))phalloidin and Neoplasm Metastasis
| Article | Year |
|---|---|
Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Biotin; Blood Platelets; Cell Adhesion; Cells, Cultured; Collagen; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Lipoxygenase Inhibitors; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Phalloidine | 1994 |